The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer
Friboulet, Luc, Li, Nanxin, Katayama, Ryohei, Lee, Christian C, Gainor, Justin F, Crystal, Adam S, Michellys, Pierre-Yves, Awad, Mark M, Yanagitani, Noriko, Kim, Sungjoon, Pferdekamper, AnneMarie C, Li, Jie, Kasibhatla, Shailaja, Sun, Frank, Sun, Xiuying, Hua, Su, McNamara, Peter, Mahmood, Sidra, Lockerman, Elizabeth L, Fujita, Naoya, Nishio, Makoto, Harris, Jennifer L, Shaw, Alice T, Engelman, Jeffrey A
Published in Cancer discovery (01.06.2014)
Published in Cancer discovery (01.06.2014)
Get full text
Journal Article
Epithelial-to-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of ALK Mutation Status
Fukuda, Koji, Takeuchi, Shinji, Arai, Sachiko, Katayama, Ryohei, Nanjo, Shigeki, Tanimoto, Azusa, Nishiyama, Akihiro, Nakagawa, Takayuki, Taniguchi, Hirokazu, Suzuki, Takeshi, Yamada, Tadaaki, Nishihara, Hiroshi, Ninomiya, Hironori, Ishikawa, Yuichi, Baba, Satoko, Takeuchi, Kengo, Horiike, Atsushi, Yanagitani, Noriko, Nishio, Makoto, Yano, Seiji
Published in Cancer research (Chicago, Ill.) (01.04.2019)
Published in Cancer research (Chicago, Ill.) (01.04.2019)
Get full text
Journal Article
Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial
Yoh, Kiyotaka, Seto, Takashi, Satouchi, Miyako, Nishio, Makoto, Yamamoto, Noboru, Murakami, Haruyasu, Nogami, Naoyuki, Matsumoto, Shingo, Kohno, Takashi, Tsuta, Koji, Tsuchihara, Katsuya, Ishii, Genichiro, Nomura, Shogo, Sato, Akihiro, Ohtsu, Atsushi, Ohe, Yuichiro, Goto, Koichi
Published in The lancet respiratory medicine (01.01.2017)
Published in The lancet respiratory medicine (01.01.2017)
Get more information
Journal Article
Real‐world study of next‐generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan
Takahashi, Toshiaki, Nishio, Makoto, Nishino, Kazumi, Yoshiki, Yasumasa, Shiraiwa, Naoko, Emir, Birol, Iadeluca, Laura, Yatabe, Yasushi, Nishio, Kazuto
Published in Cancer science (01.06.2023)
Published in Cancer science (01.06.2023)
Get full text
Journal Article
Capmatinib in Japanese patients with MET exon 14 skipping–mutated or MET‐amplified advanced NSCLC: GEOMETRY mono‐1 study
Seto, Takashi, Ohashi, Kadoaki, Sugawara, Shunichi, Nishio, Makoto, Takeda, Masayuki, Aoe, Keisuke, Moizumi, Sanae, Nomura, Satoshi, Tajima, Takeshi, Hida, Toyoaki
Published in Cancer science (01.04.2021)
Published in Cancer science (01.04.2021)
Get full text
Journal Article
Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial
Goto, Koichi, Dr, Ohe, Yuichiro, MD, Shibata, Taro, MSc, Seto, Takashi, MD, Takahashi, Toshiaki, MD, Nakagawa, Kazuhiko, Prof, Tanaka, Hiroshi, MD, Takeda, Koji, MD, Nishio, Makoto, MD, Mori, Kiyoshi, MD, Satouchi, Miyako, MD, Hida, Toyoaki, MD, Yoshimura, Naruo, MD, Kozuki, Toshiyuki, MD, Imamura, Fumio, MD, Kiura, Katsuyuki, Prof, Okamoto, Hiroaki, MD, Sawa, Toshiyuki, MD, Tamura, Tomohide, MD
Published in The lancet oncology (01.08.2016)
Published in The lancet oncology (01.08.2016)
Get full text
Journal Article
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis
Hotta, Katsuyuki, Nishio, Makoto, Saito, Haruhiro, Okamoto, Isamu, Nakahara, Yasuharu, Hayashi, Hidetoshi, Hayama, Manabu, Laud, Peter, Jiang, Haiyi, Paz-Ares, Luis, Azuma, Koichi
Published in International journal of clinical oncology (01.06.2021)
Published in International journal of clinical oncology (01.06.2021)
Get full text
Journal Article
Phase II study of ceritinib in alectinib‐pretreated patients with anaplastic lymphoma kinase‐rearranged metastatic non‐small‐cell lung cancer in Japan: ASCEND‐9
Hida, Toyoaki, Seto, Takashi, Horinouchi, Hidehito, Maemondo, Makoto, Takeda, Masayuki, Hotta, Katsuyuki, Hirai, Fumihiko, Kim, Young Hak, Matsumoto, Shingo, Ito, Masayuki, Ayukawa, Koichi, Tokushige, Kota, Yonemura, Masataka, Mitsudomi, Testuya, Nishio, Makoto
Published in Cancer science (01.09.2018)
Published in Cancer science (01.09.2018)
Get full text
Journal Article
Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial
West, Howard Jack, McCleland, Mark, Cappuzzo, Federico, Reck, Martin, Mok, Tony SK, Jotte, Robert M, Nishio, Makoto, Kim, Eugene, Morris, Stefanie, Zou, Wei, Shames, David, Das Thakur, Meghna, Shankar, Geetha, Socinski, Mark A
Published in Journal for immunotherapy of cancer (01.02.2022)
Published in Journal for immunotherapy of cancer (01.02.2022)
Get full text
Journal Article
Three-Year Follow-Up of an Alectinib Phase I/II Study in ALK-Positive Non-Small-Cell Lung Cancer: AF-001JP
Tamura, Tomohide, Kiura, Katsuyuki, Seto, Takashi, Nakagawa, Kazuhiko, Maemondo, Makoto, Inoue, Akira, Hida, Toyoaki, Yoshioka, Hiroshige, Harada, Masao, Ohe, Yuichiro, Nogami, Naoyuki, Murakami, Haruyasu, Kuriki, Hiroshi, Shimada, Tadashi, Tanaka, Tomohiro, Takeuchi, Kengo, Nishio, Makoto
Published in Journal of clinical oncology (10.05.2017)
Published in Journal of clinical oncology (10.05.2017)
Get full text
Journal Article
EBUS-TBNA as a promising method for the evaluation of tumor PD-L1 expression in lung cancer
Sakakibara, Rie, Inamura, Kentaro, Tambo, Yuichi, Ninomiya, Hironori, Kitazono, Satoru, Yanagitani, Noriko, Horiike, Atsushi, Ohyanagi, Fumiyoshi, Matsuura, Yosuke, Nakao, Masayuki, Mun, Mingyon, Okumura, Sakae, Inase, Naohiko, Nishio, Makoto, Motoi, Noriko, Ishikawa, Yuichi
Published in Clinical lung cancer (01.09.2017)
Published in Clinical lung cancer (01.09.2017)
Get full text
Journal Article
Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing
Iwama, Eiji, Sakai, Kazuko, Azuma, Koichi, Harada, Daijiro, Nosaki, Kaname, Hotta, Katsuyuki, Nishio, Makoto, Kurata, Takayasu, Fukuhara, Tatsuro, Akamatsu, Hiroaki, Goto, Koichi, Shimose, Takayuki, Kishimoto, Junji, Nakanishi, Yoichi, Nishio, Kazuto, Okamoto, Isamu
Published in Cancer science (01.12.2018)
Published in Cancer science (01.12.2018)
Get full text
Journal Article
A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy
Kiyotaka, YOH, MD, HOSOMI, Yukio, MD, PhD, KASAHARA, Kazuo, MD, PhD, YAMADA, Kazuhiko, MD, PhD, TAKAHASHI, Toshiaki, MD, YAMAMOTO, Nobuyuki, MD, PhD, NISHIO, Makoto, MD, PhD, Yuichiro, OHE, MD, PhD, Toshiko, KOUE, PhD, NAKAMURA, Takashi, MPH, ENATSU, Sotaro, MD, PhD, Pablo, LEE, MD, FERRY, David, PhD, TAMURA, Tomohide, MD, NAKAGAWA, Kazuhiko, MD, PhD
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2016)
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2016)
Get full text
Journal Article
Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK‐rearranged non–small cell lung cancer
Sakashita, Takuya, Yanagitani, Noriko, Koike, Sumie, Low, Siew‐Kee, Takagi, Satoshi, Baba, Satoko, Takeuchi, Kengo, Nishio, Makoto, Fujita, Naoya, Katayama, Ryohei
Published in Cancer science (01.11.2022)
Published in Cancer science (01.11.2022)
Get full text
Journal Article
KEYNOTE‐025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1–positive advanced non–small‐cell lung cancer
Nishio, Makoto, Takahashi, Toshiaki, Yoshioka, Hiroshige, Nakagawa, Kazuhiko, Fukuhara, Tatsuro, Yamada, Kazuhiko, Ichiki, Masao, Tanaka, Hiroshi, Seto, Takashi, Sakai, Hiroshi, Kasahara, Kazuo, Satouchi, Miyako, Han, Shi Rong, Noguchi, Kazuo, Shimamoto, Takashi, Kato, Terufumi
Published in Cancer science (01.03.2019)
Published in Cancer science (01.03.2019)
Get full text
Journal Article
Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors
Tozuka, Takehiro, Kitazono, Satoru, Sakamoto, Hiroaki, Yoshida, Hiroshi, Amino, Yoshiaki, Uematsu, Shinya, Yoshizawa, Takahiro, Hasegawa, Tsukasa, Uchibori, Ken, Yanagitani, Noriko, Horiike, Atsushi, Horai, Takeshi, Seike, Masahiro, Gemma, Akihiko, Nishio, Makoto
Published in BMC cancer (12.03.2020)
Published in BMC cancer (12.03.2020)
Get full text
Journal Article
Safety and efficacy of first‐line dacomitinib in Japanese patients with advanced non‐small cell lung cancer
Nishio, Makoto, Kato, Terufumi, Niho, Seiji, Yamamoto, Noboru, Takahashi, Toshiaki, Nogami, Naoyuki, Kaneda, Hiroyasu, Fujita, Yuka, Wilner, Keith, Yoshida, Mizuki, Isozaki, Mitsuhiro, Wada, Shinsuke, Tsuji, Fumito, Nakagawa, Kazuhiko
Published in Cancer science (01.05.2020)
Published in Cancer science (01.05.2020)
Get full text
Journal Article
Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor
Sakai, Kazuko, Horiike, Atsushi, Irwin, Darryl L., Kudo, Keita, Fujita, Yoshihiko, Tanimoto, Azusa, Sakatani, Toshio, Saito, Ryota, Kaburaki, Kyohei, Yanagitani, Noriko, Ohyanagi, Fumiyoshi, Nishio, Makoto, Nishio, Kazuto
Published in Cancer science (01.09.2013)
Published in Cancer science (01.09.2013)
Get full text
Journal Article
Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial
Jänne, Pasi A, Dr Prof, Ou, Sai-Hong I, MD, Kim, Dong-Wan, MD, Oxnard, Geoffrey R, MD, Martins, Renato, Prof, Kris, Mark G, Prof, Dunphy, Frank, Prof, Nishio, Makoto, MD, O'Connell, Joseph, MD, Paweletz, Cloud, PhD, Taylor, Ian, PhD, Zhang, Hui, PhD, Goldberg, Zelanna, MD, Mok, Tony, Prof
Published in The lancet oncology (01.12.2014)
Published in The lancet oncology (01.12.2014)
Get full text
Journal Article